Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Emdocam   
Auth. number : EU/2/11/128
Active substance : Meloxicam
ATC: Anatomical main group: QM - Musculo-skeletal system
Therapeutic subgroup: QM01 - Antiinflammatory and antirheumatic products
Pharmacological subgroup: QM01A - Antiinflammatory and antirheumatic products, non-steroids
Chemical subgroup: QM01AC - Oxicams
Chemical substance: QM01AC06 - meloxicam
(See WHO ATCvet Index)
Indication: Cattle:
For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.
For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy. For the relief of post-operative pain following dehorning in calves.
For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.
For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.
For use in the alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.
For the relief of pain associated with equine colic.
Marketing Authorisation Holder: Emdoka bvba
J. Lijsenstraat 16, 2321 Hoogstraten, België
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/08/2011 Centralised - Authorisation EMEA/V/C/2283 (2011)6047 of 18/08/2011
11/01/2012 Centralised - Variation EMEA/V/C/2283/IB/1
Updated with Decision(2012)4178 of 14/06/2012
18/06/2012 Centralised - Variation (2012)4178 of 14/06/2012
20/12/2012 Centralised - Variation EMEA/V/C/2283/IB/3/G
Updated with Decision(2013)8829 of 03/12/2013
26/03/2013 Centralised - Variation EMEA/V/C/2283/IB/4
Updated with Decision(2013)8829 of 03/12/2013
6/12/2013 Centralised - Yearly update (2013)8829 of 3/12/2013
11/04/2014 Centralised - Variation EMEA/V/C/2283/IA/5
Updated with Decision(2015)590 of 30/01/2015
10/12/2014 Centralised - Variation EMEA/V/C/2283/IB/6
Updated with Decision(2015)590 of 30/01/2015
3/02/2015 Centralised - 2-Monthly update EMEA/V/C/2283/IB/6 (2015)590 of 30/01/2015
23/06/2016 Centralised - Renewal EMEA/V/C/2283/R/7 (2016)3960 of 21/06/2016